Antitumor activity of GD2-Specific antibodies and their fab-fragments in the mouse tumor model

Immunologiya

Volumn 34, Issue 4, 2013, Pages 198-202

  Kholodenko, I V ^a   Doronin, I I ^a   Vishnyakova, P A ^a   Bolkhovitina, E L ^a   Molotkovskaya, I M ^a   Kholodenko, R V ^a  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

Antitumor therapy; Fab fragments; GD2 specific antibodies; Lymphoma EL 4; Transplantable tumor

Indexed keywords

GANGLIOSIDE GD2; IMMUNOGLOBULIN F(AB) FRAGMENT; TUMOR ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY REACTION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GRAFT; CANCER INHIBITION; CANCER THERAPY; CELL DEATH; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; CYTOTOXICITY; HALF LIFE TIME; IN VITRO STUDY; IN VIVO STUDY; LYMPHOMA; MOUSE; NONHUMAN; TUMOR GROWTH; TUMOR MODEL;

EID: 84990854106     PISSN: 02064952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Kholodenko R.V. Sovremennye problemy venerologii, immunologii i vrachebnoy kosmetologii. 2010; 8(1): 17-23 (in Russian).
2. Doronin I.I., Kholodenko I.V., Molotkovskaya I.M., Kholodenko R.V. Byulleten' eksperimental'noy biologii i meditsiny. 2012; 154(11): 616-23 (in Russian).
3. Kholodenko I.V., Doronin I.I., Kholodenko R.V. Sovremennye problemy venerologii, immunologii i vrachebnoy kosmetologii. 2010; 13(6): 79-83 (in Russian).
4. Alvarez-Rueda N., Leprieur S., Clemenceau B., et al. Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen. Clin Cancer Res. 2007; 13: 5613-20.
5. Barker E., Reisfeld R. Mechanism for neutrophil-mediated lysis of human neuroblastoma cells. Cancer Res. 1993; 53(2): 362-67.
6. Aixinjueluo W., Furukawa K., Zhang Q., et al. Mechanisms for the apoptosis of small cell lung cancer cells induced by anti-GD2 monoclonal antibodies. Journal of biological chemistry. 2005; 280(33): 29828-36.
7. Kowalczyk A., Gila M., Horwacika I., Odrowa Z., Kozborb D., Rokitaa H. The GD2-specific 14G2a monoclonal antibody induces apoptosis and enhances cytotoxicity of chemotherapeutic drugs in IMR-32 human neuroblastoma cells. Cancer Letters. 2009; 281: 171-82.
8. Zhang Z., Knoepp S.M., Ku H., Sansbury H.M., Xie Y., Chahal M.S., Tomlinson S., Meier K.E. Differential expression of FAK and Pyk2 in metastatic and non-metastatic EL4 lymphoma cell lines. Clin Exp Metastasis. 2011; 28: 551-65.
9. Kuroki M., Hachimine K., Huang J., Shibaguchi H., Kinugasa T., Maekawa S.-I., Kuroki M. Re-targeting of cytotoxic T lymphocytes and/or Natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity. Anticancer Research. 2005; 25: 3725-32.